Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)

Clinical trial NCT00951210 · COMPLETED

Trial details

NCT number: NCT00951210
Sponsor: Pluristem Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Peripheral Artery Disease Peripheral Vascular Disease Critical Limb Ischemia

Start date: 2009-08-01
Primary completion: 2011-01-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.